TIL Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
2.2M
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
2.2M
0
Operating Expenses
5.6M
-20.4%
7.0M
15.0M
-35.9%
23.4M
R&D
270.0K
-59.6%
669.0K
9.1M
-45.5%
16.7M
SG&A
5.1M
-4.1%
5.3M
5.9M
-4.3%
6.2M
Operating Income
-5581000
+20.4%
-7010000
-12780000
+45.5%
-23440000
EBITDA
-5152000
+14.2%
-6006000
-50150.0%
12.0K
+100.1%
-12768000
+44.2%
-22888000
Net Income
-4299000
-2.3%
-4204000
-13587000
+36.5%
-21394000
EPS (Basic)
$-0.63
-1.6%
$-0.62
$-2.01
+38.0%
$-3.24
EPS (Diluted)
$-0.63
-1.6%
$-0.62
$-2.01
+38.0%
$-3.24
Shares (Diluted)
6.8M
+0.0%
6.8M
-0.1%
6.8M
+0.4%
6.8M
+2.4%
6.6M
Instil Bio (TIL) — Financials